ABN Amro Investment Solutions Has $3.31 Million Stake in Axon Enterprise, Inc $AXON

ABN Amro Investment Solutions grew its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 19.6% during the first quarter, Holdings Channel.com reports. The institutional investor owned 7,805 shares of the biotechnology company’s stock after acquiring an additional 1,280 shares during the quarter. ABN Amro Investment Solutions’ holdings in Axon Enterprise were worth $3,315,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of AXON. Rockefeller Capital Management L.P. grew its stake in shares of Axon Enterprise by 53.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock worth $6,542,000 after purchasing an additional 4,002 shares during the last quarter. Legal & General Group Plc lifted its stake in Axon Enterprise by 1.3% during the fourth quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock valued at $242,241,000 after purchasing an additional 5,419 shares during the last quarter. Eurizon Capital SGR S.p.A. bought a new stake in Axon Enterprise during the fourth quarter worth approximately $13,116,000. Wealth Enhancement Advisory Services LLC boosted its holdings in Axon Enterprise by 93.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 23,365 shares of the biotechnology company’s stock worth $13,270,000 after buying an additional 11,262 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. boosted its holdings in Axon Enterprise by 40.7% during the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 15,083 shares of the biotechnology company’s stock worth $6,406,000 after buying an additional 4,360 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, President Joshua Isner sold 13,000 shares of Axon Enterprise stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the sale, the president owned 169,125 shares in the company, valued at $82,609,106.25. This trade represents a 7.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $643.79, for a total transaction of $6,437,900.00. Following the completion of the transaction, the chief executive officer owned 3,040,997 shares of the company’s stock, valued at $1,957,763,458.63. This trade represents a 0.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 58,989 shares of company stock valued at $30,527,983 over the last three months. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $491.90 on Friday. The firm has a fifty day moving average of $481.05 and a 200-day moving average of $479.43. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $885.91. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $39.65 billion, a P/E ratio of 197.55, a PEG ratio of 10.03 and a beta of 1.38.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.90 million. During the same period in the prior year, the company earned $1.47 EPS. The firm’s revenue was up 33.7% on a year-over-year basis. As a group, analysts predict that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Analysts Set New Price Targets

Several research firms have issued reports on AXON. JPMorgan Chase & Co. upped their price target on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Needham & Company LLC raised their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research note on Monday, July 6th. Barclays decreased their target price on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a report on Friday, May 8th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday. Finally, Piper Sandler upped their target price on Axon Enterprise from $674.00 to $724.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $725.25.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon added two independent directors with deep technology and AI experience — former Dell executive Vivek Mohindra and AI entrepreneur Eiso Kant — which could strengthen oversight of the company’s AI-driven public safety platform and support its long-term strategy. Axon Enterprise (AXON) Appoints Two Directors With Deep Tech And AI Experience
• Positive Sentiment: Axon announced it will report second-quarter 2026 earnings on August 5, keeping the stock in focus as investors look for proof that revenue growth can continue and that management can improve profitability. Axon to Release Second Quarter 2026 Earnings on August 5, 2026
• Positive Sentiment: Investor interest has increased around Axon as a “trending stock,” suggesting more market attention ahead of earnings and key business updates. Axon Enterprise, Inc (AXON) Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Analysts and commentary are highlighting a mixed setup: expected revenue growth remains strong, but earnings per share could soften, creating a valuation debate rather than a clear catalyst. Axon Enterprise (AXON) On Earnings Focus And AI Narrative Looks Undervalued
• Neutral Sentiment: Several articles focused on valuation, noting Axon may look expensive on cash flow but more reasonable on sales multiples, reinforcing uncertainty around whether the stock is fairly priced. Axon (AXON) Stock Could Be Fully Priced On Cash Flow Yet A Bargain On Sales
• Negative Sentiment: Margin concerns remain a headwind, with the company trying to offset rising costs through efficiency efforts while targeting stable margins in 2026 and better profitability by 2028. Can Axon Enterprise Improve Margin Performance Amid Rising Costs?

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.